Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)

NCT07119021 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Intravenous thrombolysis + edaravone
DRUG: IV thrombolysis + placebo (control group)

Sponsor

Ruijun Ji

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]